Biological Safety Testing Market: Segment of Reagents and Kits to Witness Promising Growth Due to Introduction of Innovative Technologies – BioSpace

Theglobal market for biological safety testingis showcasing a highly competitive business structure, finds a new research study by Transparency Market Research (TMR). Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group, SGS SA, Avance Biosciences, WuXi PharmaTech (Cayman) Inc., Paragon Bioservices Inc., Toxikon Inc., Nordic Scientific & Natural Solutions AB, and NuAire are some of the prominent part of the competitive landscape of this market, making it fragmented

Read more
Cell Sorting Market Research Report by Technology, by Offering, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19…

Cell Sorting Market Research Report by Technology (Fluorescence-Based Droplet Cell Sorting, Magnetic-Activated Cell Sorting (MACS), and Micro-Electromechanical System (MEMS)), by Offering (Cell Sorters, Cell Sorting Reagents & Consumables, and Cell Sorting Services), by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 New York, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Sorting Market Research Report by Technology, by Offering, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913779/?utm_source=GNW The Global Cell Sorting Market is expected to grow from USD 223.12 Million in 2019 to USD 331.32 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.81%. Market Segmentation & Coverage:This research report categorizes the Cell Sorting to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Technology, the Cell Sorting Market studied across Fluorescence-Based Droplet Cell Sorting, Magnetic-Activated Cell Sorting (MACS), and Micro-Electromechanical System (MEMS)

Read more
Opportunities in the Global Induced Pluripotent Stem Cell (iPS Cell) Industry – PRNewswire

DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report" report has been added to ResearchAndMarkets.com's offering. Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research product market has grown into existence, largely because the cells are non-controversial and can be generated directly from adult cells

Read more
Drug development for severe respiratory diseases supported with $3.9 million grant – Washington University School of Medicine in St. Louis

Visit the News Hub New drug candidate targets asthma, COPD, other progressive lung diseases Shown is a section of mouse lung with progressive lung disease, similar to asthma or COPD. The red staining shows excess mucus production that is characteristic of progressive lung disease and can occur in the aftermath of viral infection or other injury to the lungs.

Read more
Jasper Therapeutics Strengthens Management Team with Appointment of Biopharma Industry Executive Kevin N. Heller, M.D., as Executive Vice President,…

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the appointment of Kevin N. Heller, M.D., as Executive Vice President, Research & Development. In this newly created role, Dr

Read more